Tuesday, June 23, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 609 of 1,261
  1. US 9757382

    Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways

    Asana BioSciences, LLC · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted
  2. US 9757548

    Method for delivering a therapeutic agent into the wall of the small intestine

    Rani Therapeutics, LLC · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted
  3. US 9757353

    Methods of inducing anesthesia

    The Regents of the University of California · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted
  4. US 9757468

    Intranasal administration of guanidinylated aminoglycosides

    The Regents of the University of California · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted
  5. US 9758465

    Controlled release pharmaceutical formulations

    United Therapeutics Corporation · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted
  6. US 9758555

    Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor ATF5

    The Regents of the University of California · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted
  7. US 9757424

    Compositions and methods of treating gliomas

    Biomed Valley Discoveries, Inc. · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted
  8. US 9758556

    Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor ATF5

    The Regents of the University of California · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted
  9. US 9758591

    Antibodies and vaccines for use in treating ROR1 cancers and inhibiting metastasis

    The Regents of the University of California · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted
  10. US 9758483

    Pyridone amides as modulators of sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted
  11. US 9757483

    Labeled iodinated tropane formulation

    Alseres Pharmaceuticals, Inc. · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted
  12. US 9759731

    Disease severity index for assessment of chronic liver disease and method for diagnosis of three distinct subtypes of primary sclerosing cholangitis

    The Regents of the University of Colorado, a Body Corporate · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted
  13. US 9758761

    Aligned and electrospun piezoelectric polymer fiber assembly and scaffold

    The United States of America as represented by the Administrator of the National Aeronautics and Space Administration · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted
  14. US 9758529

    Fused dihydro-4H-pyrazolo[5,1-C][1,4]oxazinyl compounds and analogs for treating CNS disorders

    PGI Drug Discovery LLC · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted
  15. US 9758510

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted
  16. US 9757514

    Device, system and methods for the oral delivery of therapeutic compounds

    Rani Therapeutics, LLC · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted
  17. US 9758775

    TAL effector-mediated DNA modification

    Regents of the University of Minnesota · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted
  18. US 9757544

    Drug releasing coatings for medical devices

    Lutonix, Inc. · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted
  19. US 9758831

    Methods of predicting clinical course and treating multiple sclerosis

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted
  20. US 9757472

    Proteas stabilized antibacterial peptides for S. aureus

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted
  21. US 9757425

    Method and composition for synchronizing time of insemination

    JBS United Animal Health II LLC · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted
  22. US 9757466

    Methods and compositions for deterring abuse

    Acurx Pharmaceuticals, Inc. · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted
  23. US 9757454

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted
  24. US 9757384

    Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome

    ESSENTIALIS, INC. · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.